Clinical trial · Interventional
The HPV Self-test as a Test of Cure in Madagascar
The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar
NCT02811367CI-TRIAL-00024313completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to find out whether Self-HPV may be an accurate method for the follow-up of women with a history of HPV infection.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical Intraepithelial Neoplasia Grade 2/3 | ONTOLOGY_EXACT | 0.98 |
| Human Papilloma Virus Infection | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV test | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HPV self-test
- description
- Women will perform the HPV self-test.
- interventionNames
- Device: HPV test
Primary outcomes (1)
- measure
- Cervical intra-epithelial neoplasia grade 2 or worse
- timeFrame
- 4 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * women previously positive at HPV testing Exclusion Criteria: * pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.